Labelling of Y- and Lu-DOTA-Bioconjugates for Targeted Radionuclide Therapy: A Comparison among Manual, Semiautomated, and Fully Automated Synthesis

Figure 3

Images of the ML Eazy device (a), a disposable cassette (b), and disposable cassettes assembled onto the system (c). Delivery vial (⁹⁰Y and ¹⁷⁷Lu-chloride solutions) (1), reagent vial (precursor and buffer solution) (2), reactor vial (3), waste vial (4), 0.9% NaCl solution vial (5), and product vial (6).

(a)

(b)

(c)